(S)-3,4-DCPG - CAS 201730-11-2
Catalog number: 201730-11-2
Category: Main Product
Molecular Formula:
C10H9NO6
Molecular Weight:
239.18
COA:
Inquire
Publictions citing BOC Sciences Products
  • >> More
Purity:
≥99%
Appearance:
White solid
Synonyms:
(S)-3,4-DICARBOXYPHENYLGLYCINE; (S)-3,4-DCPG; UBP1109
MSDS:
Inquire
InChIKey:
IJVMOGKBEVRBPP-ZETCQYMHSA-N
InChI:
InChI=1S/C10H9NO6/c11-7(10(16)17)4-1-2-5(8(12)13)6(3-4)9(14)15/h1-3,7H,11H2,(H,12,13)(H,14,15)(H,16,17)/t7-/m0/s1
Canonical SMILES:
C1=CC(=C(C=C1C(C(=O)O)N)C(=O)O)C(=O)O
1.The metabotropic glutamate receptor 8 agonist (S)-3,4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson's disease.
Johnson KA1, Jones CK, Tantawy MN, Bubser M, Marvanova M, Ansari MS, Baldwin RM, Conn PJ, Niswender CM. Neuropharmacology. 2013 Mar;66:187-95. doi: 10.1016/j.neuropharm.2012.03.029. Epub 2012 Apr 21.
Metabotropic glutamate receptors (mGlus) are 7 Transmembrane Spanning Receptors (7TMs) that are differentially expressed throughout the brain and modulate synaptic transmission at both excitatory and inhibitory synapses. Recently, mGlus have been implicated as therapeutic targets for many disorders of the central nervous system, including Parkinson's disease (PD). Previous studies have shown that nonselective agonists of group III mGlus have antiparkinsonian effects in several animal models of PD, suggesting that these receptors represent promising targets for treating the motor symptoms of PD. However, the relative contributions of different group III mGlu subtypes to these effects have not been fully elucidated. Here we report that intracerebroventricular (icv) administration of the mGlu(8)-selective agonist (S)-3,4-dicarboxyphenylglycine (DCPG [ 2.5, 10, or 30 nmol]) does not alleviate motor deficits caused by acute (2 h) treatment with haloperidol or reserpine.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Chemical Structure

CAS 201730-11-2 (S)-3,4-DCPG

Quick Inquiry

Verification code

Featured Items